èšåºæ®µéã®ãã€ãªå»è¬åäŒæ¥ã§ãã Akari Therapeutics, Plc ã¯ãè£äœããã³ãã€ã³ããªãšã³çµè·¯ãé¢äžããèªå·±ççæ§çŸæ£ã®æ²»çè¬ã®éçºãšåååã«æ³šåããŠããŸããå瀟ã®äž»å補ååè£ã¯ãçºäœæ§å€éãã¢ã°ããã³å°¿çãã®ã©ã³ãã¬ãŒçå矀ãé è¡å¹¹çްèç§»æ€é¢é£è¡æ æ§åŸ®å°è¡ç®¡çãæ°Žç±æ§é¡å€©ç±ç¡ãªã©ã®èªå·±å
ç«çŸæ£ããã³ççæ§çŸæ£ã®æ²»çè¬ãšããŠç¬¬ II çžèšåºè©Šéšãè¡ãããŠãã第 2 äžä»£è£äœé»å®³å€ã§ããããã³ãã³ã§ããAkari Therapeutics, Plc ã¯è±åœãã³ãã³ã«æ ç¹ã眮ããŠããŸãã